TTY Biopharm
26
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
15.4%
4 terminated/withdrawn out of 26 trials
69.2%
-17.3% vs industry average
19%
5 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
Evaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence Study
Role: lead
Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)
Role: collaborator
A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
Role: lead
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer
Role: collaborator
A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency
Role: lead
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
Role: lead
A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Role: lead
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
Role: collaborator
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
Role: lead
A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan
Role: collaborator
TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
Role: lead
A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever
Role: lead
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
Role: collaborator
Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT
Role: lead
Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer
Role: collaborator
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Role: collaborator
A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
Role: lead
Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux
Role: lead
Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances
Role: collaborator
Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Role: lead